Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 1,873-1,884 of 4,306
Drug study icon
CompletedNCT00604279

A Comparative Study of Paliperidone Palmitate and Risperidone Long Acting Injection (LAI) in people with Schizophrenia

This study is completed in China. It is testing Paliperidone Palmitate and Risperidone Long Acting Injection (LAI) for schizophrenia.

Multiple locations, including Baoding
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.Over 18 Years
Countries
China
Sponsor
Xian-Janssen Pharmaceutical Ltd.
Condition
Schizophrenia
Drug study icon
CompletedNCT01086748

A Comparator Study of LY2140023 Versus Placebo in Schizophrenia Patients

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Escondido
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, Croatia, Russia
Sponsor
Denovo Biopharma LLC
Condition
Schizophrenia
Drug study icon
CompletedNCT00034905

A Comparison of Seroquel vs. Risperidone in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Birmingham
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
AstraZeneca
Condition
Schizophrenia
Drug study icon
CompletedNCT00843687

A Comparison of the Pharmacokinetics and Safety of Long-acting Injectable Risperidone When Administered to Gluteal or Deltoid Intramuscular Injection Sites in Stable Schizophrenia Patients.

This study is completed. It focuses on schizophrenia.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia
Other study type icon
Active Not RecruitingNCT07618767

A Computational Neuroscience Perspective on the Shared Social Cognitive Deficits of Autism and Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Taipei
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.Over 18 Years
Countries
Taiwan
Sponsor
National Taiwan University Hospital
Condition
Schizophrenia
Drug study icon
CompletedNCT01451164

A Dose-finding study of OPC-34712 in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Kanto Region
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
Japan
Sponsor
Otsuka Pharmaceutical Co., Ltd.
Condition
Schizophrenia
Device study icon
CompletedNCT00168311

Double-Blind Placebo Controlled Trial of Repetitive Transcranial Magnetic Stimulation in the Treatment of Negative Symptoms for schizophrenia

This study is completed in Australia. It is testing Double-Blind Placebo Controlled Trial of Repetitive Transcranial Magnetic Stimulation in the Treatment of Negative Symptoms for schizophrenia.

In Melbourne
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 70 Years
Countries
Australia
Sponsor
The Alfred
Condition
Schizophrenia
Drug study icon
CompletedNCT00518323

Safety and Efficacy of Paliperidone Extended Release (ER) for schizophrenia

This study is completed in the United States, in India, in Romania, .... It is testing Safety and Efficacy of Paliperidone Extended Release (ER) for schizophrenia.

Multiple locations, including Cerritos
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 12 Years to 17 Years
Countries
United States, India, Romania, ...
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.